Literature DB >> 9000679

Hepatitis C virus-related fibrosing cholestatic hepatitis after renal transplantation.

H Zylberberg1, F Carnot, M F Mamzer, G Blancho, C Legendre, S Pol.   

Abstract

Fibrosing cholestatic hepatitis is a well-described syndrome in patients with immunodeficiency and chronic hepatitis B. It is clinically, biologically, and histologically characterized by rapidly progressive hepatic failure, a mildly elevated serum aminotransferase level, an extensive periportal fibrosis associated with intense cholestasis, mild inflammatory cellular infiltrate, no cirrhosis, and a high hepatocellular level expression of B viral antigens. This syndrome reflected a direct hepatocytopathic injury linked to high intrahepatic viral antigen expression. Because the syndrome of fibrosing cholestatic hepatitis has not been described in chronic hepatitis C, we report the first well-characterized case in a renal transplant patient with chronic hepatitis C and discuss the clinical and pathogenic implications of such a syndrome in this setting.

Entities:  

Mesh:

Year:  1997        PMID: 9000679     DOI: 10.1097/00007890-199701150-00029

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  13 in total

1.  Early diagnosis and treatment resolved cholestatic hepatitis C without fibrosis after living donor liver transplantation: report of a case.

Authors:  Takasuke Fukuhara; Kazutoyo Morita; Kazuki Takeishi; Takeo Toshima; Kenji Umeda; Shigeyuki Nagata; Keishi Sugimachi; Toru Ikegami; Tomonobu Gion; Yuji Soejima; Akinobu Taketomi; Yoshihiko Maehara
Journal:  Surg Today       Date:  2010-09-25       Impact factor: 2.549

Review 2.  Hepatitis C: Current Controversies and Future Potential in Solid Organ Transplantation.

Authors:  Lucy Somerville; Karen Doucette
Journal:  Curr Infect Dis Rep       Date:  2018-05-22       Impact factor: 3.725

Review 3.  Fibrosing cholestatic hepatitis in renal transplant recipient with CMV infection: a case report.

Authors:  S K Agarwal; V Kalra; Amit Dinda; S Gupta; S C Dash; D Bhowmik; S C Tiwari
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

4.  Fibrosing cholestatic hepatitis with hepatitis C virus treated by double filtration plasmapheresis and interferon plus ribavirin after liver transplantation.

Authors:  Teruki Miyake; Kojiro Michitaka; Yoshio Tokumoto; Shinya Furukawa; Teruhisa Ueda; Yoshiko Soga; Masanori Abe; Bunzo Matsuura; Taro Nakamura; Taiji Tohyama; Nobuaki Kobayashi; Yoichi Hiasa; Morikazu Onji
Journal:  Clin J Gastroenterol       Date:  2009-01-10

5.  Fibrosing cholestatic hepatitis in a kidney transplant recipient with hepatitis C virus.

Authors:  Takahiro Shinzato; Taro Kubo; Toshihiro Shimizu; Koji Nanmoku; Takashi Yagisawa
Journal:  CEN Case Rep       Date:  2019-01-02

6.  Fibrosing cholestatic hepatitis: clinicopathologic spectrum, diagnosis and pathogenesis.

Authors:  Shu-Yuan Xiao; Liang Lu; Hanlin L Wang
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

Review 7.  Natural history, treatment and prevention of hepatitis C recurrence after liver transplantation: past, present and future.

Authors:  Jérôme Dumortier; Olivier Boillot; Jean-Yves Scoazec
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

Review 8.  Hepatitis C in non-hepatic solid organ transplant candidates and recipients: A new horizon.

Authors:  Sara Belga; Karen Elizabeth Doucette
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

9.  Seronegative hepatitis C-related fibrosing cholestatic hepatitis after renal transplant: a case report and review of the literature.

Authors:  Nathan J Shores; James Kimberly
Journal:  NDT Plus       Date:  2008-04-05

10.  Selected biochemical and hematological abnormalities in Nigerians with human immunodeficiency virus and hepatitis C virus coinfection.

Authors:  Olive Obienu; Sylvester Nwokediuko
Journal:  Hepat Med       Date:  2011-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.